1720P How do oncological patients perceive the COVID-19 pandemic? Experience from CHU Liège in Belgium

Onesti, Concetta Elisa; Schroeder, Hélène; Rorive, Andrée; Sautois, Brieuc; Lecocq, Marie; Goffin, Marie; Gonne, Elodie; Collinge, A.; Nicolaers, Laurence; Wéra, Odile; Catot, Amandine; Loly, Catherine; Paulus, Astrid; Sibille, Anne; Lousberg, Laurence; Troisfontaine, F; Collignon, Joëlle; Gennigens, Christine; Freres, Pierre; Jérusalem, Guy

doi:10.1016/j.annonc.2020.08.1784

Cited by 2 publications

(2 citation statements)

References 0 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“… 14 In addition to oncologic care, other areas have been impacted by the COVID-19 pandemic, such as medical education, scientific activity, and the well-being of both patients and healthcare staff. 15 – 17 These changes are likely to have short- and long-term impact.…”

Section: Introductionmentioning

confidence: 99%

Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology

Onesti

Tagliamento

Curigliano

et al. 2021

JCO Global Oncology

View full text Add to dashboard Cite

PURPOSE The COVID-19 pandemic has affected healthcare systems globally, leading to reorganization of medical activities. We performed an international survey aimed to investigate the medium- and long-term impact on oncology units. MATERIALS AND METHODS An 82-item survey was distributed from June 17 to July 14, 2020 among medical oncologists worldwide. RESULTS One hundred nine medical oncologists from 18 countries in Europe (n = 93), United States (n = 5), and Latin America (n = 11) answered the survey. A systematic tracing of COVID-19–positive patients was continued in the postacute phase by 77.1% of the centers; 64.2% of the respondents participated in a local registry and 56% in international or national registries of infected patients. Treatment adaptations were introduced, and surgery was the most affected modality being delayed or canceled in more than 10% of patients in 34% of the centers, whereas early cessation of palliative treatment was reported in 32.1% of the centers; 64.2% of respondents reported paying attention to avoid undertreatments. The use of telemedicine has been largely increased. Similarly, virtual tools are increasingly used particularly for medical education and international or national or multidisciplinary meetings. 60.6% of the participants reduced clinical activity, and 28.4% compensated by increasing their research activity. Significant reduction of clinical trial activities is expected in 37% of centers this year. The well-being of healthcare staff would not recover by the end of the year according to 18% of the participants. CONCLUSION The COVID-19 outbreak has had a major impact on oncologic activity, which will persist in the future, irrespective of geographical areas.

show abstract

Section: Introductionmentioning

confidence: 99%

Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology

Onesti

Tagliamento

Curigliano

et al. 2021

JCO Global Oncology

View full text Add to dashboard Cite

show abstract

“…Dutch guidelines also recommend using neoadjuvant hormonal treatment for breast cancer patients with hormone-receptor positive breast cancers (Eijkelboom et al, 2021 [3]). Researchers also developed algorithms to help identify an adequate treatment option based on patient risks (Mori et al, 2020[59]; Office for National Statistics, 2021 [60]).…”

mentioning

confidence: 99%

Impact of the COVID-19 pandemic on cancer care in OECD countries

2022

OECD Health Working Papers

View full text Add to dashboard Cite

The COVID-19 pandemic has disrupted primary and secondary prevention efforts as well as routine care related to the diagnosis and treatment of cancer. The number of cancer-related procedures declined across countries, as much as 40% in some of the reporting countries. Many of the OECD countries also faced challenges in maintaining and further improving cancer care quality and outcomes during the pandemic. This paper compiles initial findings as well as emerging evidence from a subset of OECD countries covering the period from March 2020 to August 2021. It illustrates how several of these countries attempted to mitigate the impact of COVID-19 on cancer care systems. There have been examples of adapting treatment guidelines, changing clinical practices and reducing backlogs to minimise negative impacts of the pandemic on cancer patients. Several of the countries also undertook more frequent monitoring and in-depth analysis of cancer care performance to help develop more targeted risk-based approaches in providing cancer screening and care. The analyses also confirm that strong health information infrastructure is crucial for developing resilient health systems that provide effective, timely and people-centred cancer care.

show abstract

1720P How do oncological patients perceive the COVID-19 pandemic? Experience from CHU Liège in Belgium

Cited by 2 publications

References 0 publications

Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology

Expected Medium- and Long-Term Impact of the COVID-19 Outbreak in Oncology

Impact of the COVID-19 pandemic on cancer care in OECD countries

Contact Info

Product

Resources

About